Lundbeck
HLUN-B.CO
#2871
Rank
C$5.98 B
Marketcap
$6.22
Share price
-0.14%
Change (1 day)
-3.29%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): $0.48

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.49. In 2022 the company made an earnings per share (EPS) of $0.37 a decrease over its 2021 EPS that were of $0.84.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.4828.23%
2022$0.37-55.47%
2021$0.84-51.83%
2020$1.74-28.01%
2019$2.41-44.08%
2018$4.3151.94%
2017$2.84126.64%
2016$1.25-120.84%
2015-$6.015622.18%
2014-$0.11-110.03%
2013$1.05-28.08%
2012$1.46-52.1%
2011$3.04-1.31%
2010$3.0815.61%
2009$2.66